START FREE TRIAL

Ishan Majumdar

Sandisk Stock Surge AI Catalyst Revealed—& 27% Jump Is Not Just Hype!

Sandisk (NASDAQ:SNDK) just logged its biggest single-day gain in nearly a year, soaring 27.6% to a record $349.63. It...

Palantir Venezuela Maduro Impact: The Real Story Behind the Headlines!

Shares of Palantir Technologies (NYSE:PLTR) jumped after a dramatic weekend operation in which Venezuelan leader Nicolás Maduro was captured...

Tesla 2025 EV Deliveries Decline: Europe Turns Its Back on Musk

Tesla (NASDAQ:TSLA) just reported a bruising end to 2025. Fourth-quarter deliveries came in at 418,227 units—down 16% from the...

Target Activist Investor Stake: What a $5B Catalyst Means for Stores, Labor & Margins

Target (NYSE:TGT) had a bruising 2025. Sales slid for the second straight year, the stock dropped 28%, and the...

Meta Acquires Manus: The Real Reason Behind Zuckerberg’s $2 Billion AI Gamble

Meta Platforms (NASDAQ:META) just made another bold AI move. In a deal reportedly valued north of $2 billion, Meta...

An Investor’s Guide To Intrinsic Value Calculation & Relative Valuation

Valuation can feel intimidating when you first encounter it. There are formulas everywhere, specialized jargon, and spreadsheets packed with...
spot_imgspot_img

Nvidia Groq AI Licensing Deal Hints At What Comes After GPU Dominance

On Christmas Eve, when markets were thin and inboxes quiet, Nvidia (NASDAQ:NVDA) dropped a small but revealing piece of...

Chevron Venezuela Oil Investment: Trump’s Secret Weapon Against Maduro?

Chevron’s (NYSE:CVX) century-long presence in Venezuela is turning into a high-stakes test of geopolitics, oil strategy, and corporate resilience....

Sterling Anderson GM Leadership Gamble: Can a Tesla Defector Save General Motors?

Sterling Anderson’s journey from clashing with Elon Musk to reshaping General Motors (NYSE:GM) may be one of the most...

Niagen NR Patent Acquisition Unlocks Massive Pharma Potential—But There’s a Catch!

If you blinked, you may have missed one of the more intriguing biotech moves of the year. Niagen Bioscience...

Howmet Buys CAM: The $1.8 Billion Bet That Could Reshape Aerospace

On December 22, 2025, Howmet Aerospace (NYSE:HWM) announced plans to acquire Consolidated Aerospace Manufacturing (CAM) from Stanley Black &...

BioMarin Amicus Acquisition: A $4.8 Billion Bet on Rare Disease Domination

BioMarin Pharmaceutical (NASDAQ:BMRN) just made its boldest move in years—unveiling a $4.8 billion all-cash acquisition of Amicus Therapeutics. The...